World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: IRCT
Last refreshed on: 30 April 2018
Main ID:  IRCT20100829004655N9
Date of registration: 2018-03-25
Prospective Registration: Yes
Primary sponsor: Kashan University of Medical Sciences
Public title: Comparison of the effect Emla Cream? local lavender essential oil and Cold Compress on the pain intensity of the injection site and Comfort of heart Patients Receiving Enoxaparin
Scientific title: Comparison of the effect Emla Cream? local lavender essential oil and Cold Compress on the pain intensity of the injection site and Comfort of heart Patients Receiving Enoxaparin
Date of first enrolment: 2018-04-04
Target sample size: 100
Recruitment status: Recruiting
URL:  http://en.irct.ir/trial/29551
Study type:  interventional
Study design:  Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: The sampling method is continuous The patients were randomly assigned to three intervention groups and one control group, Blinding description: patient and researcher measurement pain and comfort are blind.  
Phase:  2
Countries of recruitment
Iran (Islamic Republic of)
Contacts
Name: Taghadosi Mohsen   
Address:  Ghotb Ravandi Blvd, Kashan 8715988141 Kashan Iran (Islamic Republic of)
Telephone: +98 36 1555 0021
Email: taghadosi_m@kaums.ac.ir
Affiliation:  Kashan University of Medical Sciences
Name: badry torki   
Address:  Ghotb Ravandi Blvd, Kashan 87159/81151 Kashan Iran (Islamic Republic of)
Telephone: +98 31 5554 0021
Email: taghadosi_m@kaums.ac.ir
Affiliation:  Kashan University of Medical Sciences
Key inclusion & exclusion criteria
Inclusion criteria: 1.age between 18-85 years old
full consciousness
ability to communicate
not a severe pain in other areas
no history of prescribed Enoxaparin
no scarring and lesions at the injection site
no history of allergy to lidocaine & Prilocain
no history of allergy to Lavender

Exclusion criteria: loss of consciousness
prescription of narcotic and non-narcotic analgesics 2 hours before injection
injection of other drug in the abdomen during the study


Age minimum: 18 years
Age maximum: 85 years
Gender: Both
Health Condition(s) or Problem(s) studied
Injection pain.
Other acute postprocedural pain
G89.18
Intervention(s)
Intervention 1: First intervention group :In this method 1gr Emla cream is placed on the injection site with holder dressing 60 minute before the injection and dressing is removed after the one hour, then area is cleaned and injection is performed. Intervention 2: Second intervention group: In this method, a piece of ice the size of 3*2*2 Cm is placed inside the latex gloves and is placed on the injection site 5 minute before the injection. Intervention 3: Third intervention group:2 ml of lavender oil 10% will apply for 5 minutes before injection on the injection site and after 20 minutes, the skin will be cleaned and injected. Intervention 4: Control group:Enoxaparin injection without intervention.
Primary Outcome(s)
Injection pain. Timepoint: Immediate,5 &10 minute after injection. Method of measurement: Using the VAS scale & record severe pain intensity.
The amount Patient comfort. Timepoint: Immediate,5 &10 minute after injection. Method of measurement: visual scale of comfor& record severe comfort intensity Using the.
Secondary Outcome(s)
Secondary ID(s)
Source(s) of Monetary Support
Kashan University of Medical Sciences
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date:
Contact:
Kashan University of Medical Sciences
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history